Displaying 5341 - 5360 of 5993
| Contract Number | Brand Code | Brand Name | Package Size | Formulary Category | Unit Price | Strength | Max. Reimbursable / Month | Drug Contract Start Date | Drug Contract End Date | Restrict To Ophthalmologist | Restrict To Pulmonologist | Status Description | Max Repeats | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41 | A6812 | COMBIVIR 150MG|300MG TAB (GSK) LAMIVUDINE|ZIDOVUDINE (BL) | 60'S | BL | 2.4972 | 150MG|300MG | 60 | 2024-04-01 | 2026-03-31 | 6 | ||||
| 40 | A681AM | EFAVIRENZ | EMTRICITABINE | TENOFOVIR 600MG | 200MG | 300MG TAB (MAT/AHI) | 30'S | BL | 0.92 | 600MG|200MG|300MG | 0 | 2022-04-01 | 2024-03-31 | 0 | ||||
| 41 | A681AM | EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (MAT (BL) | 30'S | BL | 1.0058 | 600MG|200MG|300MG | 60 | 2024-04-01 | 2026-03-31 | 6 | ||||
| 42 | A681AM | EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (MAT | 30'S | BL | 0.92 | 600MG|200MG|300MG | 60 | 2026-04-01 | No | No | 0 | |||
| 40 | A681BN | KIVEXA 600MG | 300MG TAB (GSK/COL) ABACAVIR | LAMIVUDINE | 30'S | BL | 5.40 | 600MG|300MG | 0 | 2022-04-01 | 2024-03-31 | 0 | ||||
| 40 | A681EY | VONAVIR 600MG | 200MG | 300MG TAB (EMC/COL) EFAVIRENZ | EMTRICITABINE | TENOFOVI More ... | 30'S | BL | 2.72 | 600MG|200MG|300MG | 0 | 2022-04-01 | 2024-03-31 | 0 | ||||
| 41 | A681EY | VONAVIR 600MG|200MG|300MG TAB (EMC) EFAVIRENZ|EMTRICITABINE| (BL) | 30'S | BL | 2.8995 | 600MG|200MG|300MG | 60 | 2024-04-01 | 2026-03-31 | 6 | ||||
| 42 | A681EY | VONAVIR 600MG|200MG|300MG TAB (EMC) EFAVIRENZ|EMTRICITABINE| | 30'S | BL | 2.90 | 600MG|200MG|300MG | 60 | 2026-04-01 | No | No | 0 | |||
| 40 | A681FC | KIVALA 600MG | 300MG TAB (REM/SBI) ABACAVIR | LAMIVUDINE | 30'S | BL | 2.76 | 600MG|300MG | 0 | 2022-04-01 | 2024-03-31 | 0 | ||||
| 42 | A681FC | KIVALA 600MG|300MG TAB (REM) ABACAVIR|LAMIVUDINE | 30'S | BL | 1.92 | 600MG|300MG | 30 | 2026-04-01 | No | No | 0 | |||
| 41 | A681FS | EXATRON 200MG|245MG TAB (REM) EMTRICITAB (BL) | 30'S | BL | 2.5371 | 200MG|245MG | 0 | 2024-04-01 | 2026-03-31 | 0 | ||||
| 40 | A681FT | TAVIN-EM 200MG | 300MG TAB (EMC/COL) EMTRICITABINE | TENOFOVIR | 30'S | BL | 0.71 | 200MG|300MG | 0 | 2022-04-01 | 2024-03-31 | 0 | ||||
| 41 | A681FT | TAVIN-EM 200MG|300MG TAB (EMC) EMTRICITABINE|TENOFOVIR (BL) | 30'S | BL | 0.9378 | 200MG|300MG | 60 | 2024-04-01 | 2026-03-31 | 6 | ||||
| 40 | A681GL | TRUVADA 200MG | 300MG TAB (GIL/COL) EMTRICITABINE | TENOFOVIR | 30'S | BL | 4.32 | 200MG|300MG | 0 | 2022-04-01 | 2024-03-31 | 0 | ||||
| 41 | A681GL | TRUVADA 200MG|300MG TAB (GIL) EMTRICITABINE|TENOFOVIR (BL) | 30'S | BL | 4.3176 | 200MG|300MG | 60 | 2024-04-01 | 2026-03-31 | 6 | ||||
| 40 | A681GP | ATAZOR-R 300MG | 100MG TAB (EMC/COL) ATAZANAVIR | RITONAVIR | 30'S | BL | 2.50 | 300MG|100MG | 0 | 2022-04-01 | 2024-03-31 | 0 | ||||
| 41 | A681GP | ATAZOR-R 300MG|100MG TAB (EMC) ATAZANAVIR|RITONAVIR (BL) | 30'S | BL | 2.2653 | 300MG|100MG | 60 | 2024-04-01 | 2026-03-31 | 6 | ||||
| 42 | A681GP | ATAZOR-R 300MG|100MG TAB (EMC) ATAZANAVIR|RITONAVIR | 30'S | BL | 2.45 | 300MG|100MG | 60 | 2026-04-01 | No | No | 0 | |||
| 42 | A681GQ | ABACAVIR|LAMIVUDINE 600MG|300MG TAB (CIP) | 30'S | BL | 6.12 | 600MG|300MG | 30 | 2026-04-01 | No | No | 0 | |||
| 40 | A681GW | BIKTARVY 50MG | 200MG | 25MG TAB (GIL/COL) BICTEGRAVIR | EMTRICITABINE | TENOFOV More ... | 30'S | BL | 10.73 | 50MG|200MG|25MG | 0 | 2022-04-01 | 2024-03-31 | 0 | ||||